Hemoperfusion with the Cytosorb device in a patient with severe COVID-19
Revista Colombiana de Nefrologia
; 8(1), 2021.
Article
in Spanish
| Scopus | ID: covidwho-1687733
ABSTRACT
The COVID-19 disease is an infectious disease caused by the SARS-CoV 2 virus whose clinical presentation is very heterogeneous it can range from asymptomatic people to critically ill patients, with cytokine storm, acute respiratory distress, organ dysfunction and even death. Current therapies for its treatment are aimed at reducing the impact of the inflammatory cascade, and within these we find hemoadsorption technologies such as the CytoSorb membrane. Next, we present a 31-year-old male patient, who consulted due to severe symptoms of COVID-19 and showed an evident clinical and biochemical improvement after using the CytoSorb device. This is the only documented patient in Colombia who has undergone haemoperfusion therapy with this device in conjunction with prolonged intermittent renal replacement therapy and favorable clinical outcomes have been recorded. © 2021, Asociacion Colombiana de Nefrologia e Hipertension Arterial. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Language:
Spanish
Journal:
Revista Colombiana de Nefrologia
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS